Search results
Amgen's (AMGN) Stock Rallies Almost 5% on Broker Upgrade
Zacks via Yahoo News· 9 months agoAmgen AMGN stock was up 4.6% on Wednesday after Leerink Partners upgraded the stock’s rating and...
Walgreens to take a hard look at underperforming stores, could shutter hundreds more
Associated Press via Yahoo News· 1 week agoWalgreens is finalizing a plan to fix its U.S. business that could result in closing hundreds of...
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Zacks via Yahoo News· 1 month agoData from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...
Wall Street Research Firm MoffettNathanson Goes Indie Again After Bankruptcy of Parent Company
Variety via Yahoo News· 9 months agoMoffettNathanson, a leading Wall Street research outfit covering the media and communications...
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance· 2 months agoJust a few short years after coming to market, the latest GLP-1 drugs are showing versatility in...
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
Yahoo Finance· 2 months agoAstraZeneca's (AZN) stock is up following its latest earnings report Thursday after the company...
Novo Nordisk is the 2023 Yahoo Finance Company of the Year
Yahoo Finance· 7 months agoNovo Nordisk was the talk of the pharma and medical world this year — and also the world of People...
UnitedHealth shares tumble after health care giant reports soaring medical costs in 4Q
Associated Press via Yahoo News· 6 months agoUnitedHealth Group turned in a better-than-expected fourth quarter but surprised Wall Street with...
Alzheimer's drug Leqembi: The twice-monthly infusion could be available in injection form
Yahoo Finance· 8 months agoMakers of the new Alzheimer's drug, Leqembi, say their twice-monthly infusion could be available in...
The battle for weight loss drug dominance is heating up. Here's why.
Yahoo Finance· 8 months agoThe race to grab market share of the booming obesity drug market has officially begun, with...